Success Metrics

Clinical Success Rate
60.0%

Based on 3 completed trials

Completion Rate
60%(3/5)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
2(33%)

Phase Distribution

Ph not_applicable
1
17%
Ph phase_4
1
17%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Phase 4Post-market surveillance
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

3 of 6 finished

Non-Completion Rate

50.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(3)
Terminated(3)

Detailed Status

Completed3
Terminated2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
60.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (50.0%)
N/A1 (50.0%)

Trials by Status

terminated233%
withdrawn117%
completed350%

Recent Activity

0 active trials
Showing 5 of 6
completednot_applicable

Procalcitonin Antibiotic Consensus Trial (ProACT)

NCT02130986
completed

Predicting the Severity of Post-cesarean Wound Infections Using Serum Procalcitonin Levels

NCT03223233
completed

Serum Procalcitonin Study in the Management of Ventilated Patients

NCT00726167
withdrawn

The Natural History of Procalcitonin in Hemorrhagic Stroke

NCT01498705
terminatedphase_4

Study of Procalcitonin (PCT)-Guided Antibiotic Use in Severe Sepsis Patients Without Obvious Infection

NCT01025180
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT02130986Not Applicable

Procalcitonin Antibiotic Consensus Trial (ProACT)

Completed
NCT03223233

Predicting the Severity of Post-cesarean Wound Infections Using Serum Procalcitonin Levels

Completed
NCT00726167

Serum Procalcitonin Study in the Management of Ventilated Patients

Completed
NCT01498705

The Natural History of Procalcitonin in Hemorrhagic Stroke

Withdrawn
NCT01025180Phase 4

Study of Procalcitonin (PCT)-Guided Antibiotic Use in Severe Sepsis Patients Without Obvious Infection

Terminated
NCT00498121

The Diagnostic and Prognostic Utility of Procalcitonin (ProCT) for Ventilator-associated Pneumonia (VAP)

Terminated

All 6 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
6